Sentire says attacks began June 29 against a CVSS 9.6 OS command injection flaw that enables unauthenticated code execution.

Researchers have discovered two vulnerabilities in the widely used Cursor AI-enabled integrated development environment (IDE) ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AHM Group's recent acquisition ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...